Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanne ten Broeke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|October 1, 2015
ClinGen and Genetic TestingMaartje Nielsen, Sanne ten Broeke, Rolf Sijmons
European Journal of Human Genetics : EJHG|October 17, 2019
The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded materialAnne M L Jansen, Carli M J Tops, Dina Ruano, et al.
International Journal of Cancer|October 10, 2022
Is HLA type a possible cancer risk modifier in Lynch syndrome?Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
Nature Communications|September 22, 2020
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolutionAlexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, et al.
Hereditary Cancer in Clinical Practice|March 13, 2019
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database reportToni T Seppälä, Aysel Ahadova, Mev Dominguez-Valentin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|October 1, 2015
ClinGen and Genetic TestingMaartje Nielsen, Sanne ten Broeke, Rolf Sijmons
European Journal of Human Genetics : EJHG|October 17, 2019
The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded materialAnne M L Jansen, Carli M J Tops, Dina Ruano, et al.
International Journal of Cancer|October 10, 2022
Is HLA type a possible cancer risk modifier in Lynch syndrome?Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
Nature Communications|September 22, 2020
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolutionAlexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, et al.
Hereditary Cancer in Clinical Practice|March 13, 2019
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database reportToni T Seppälä, Aysel Ahadova, Mev Dominguez-Valentin, et al.
Pageof 1